Incidence and impact of non-canonical JAK2 p.(Val617Phe) mutations in myeloproliferative neoplasm molecular diagnostics.

IF 2.5 4区医学 Q2 PATHOLOGY

Journal of Clinical Pathology Pub Date : 2025-01-17 DOI:10.1136/jcp-2023-209276

Danielle Patchell, Clodagh Keohane, Susan O'Shea, Stephen E Langabeer

引用次数: 0

查看原文本刊更多论文

骨髓增生性肿瘤分子诊断中非典型 JAK2 p.(Val617Phe) 突变的发生率和影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Clinical Pathology 医学-病理学

CiteScore

7.80

自引率

2.90%

发文量

113

审稿时长

3-8 weeks

期刊介绍： Journal of Clinical Pathology is a leading international journal covering all aspects of pathology. Diagnostic and research areas covered include histopathology, virology, haematology, microbiology, cytopathology, chemical pathology, molecular pathology, forensic pathology, dermatopathology, neuropathology and immunopathology. Each issue contains Reviews, Original articles, Short reports, Correspondence and more.